# Cholesterol Metabolites Analysis in Human Thyroid and Iodine Resistance

> **NCT04821336** · — · COMPLETED · sponsor: **Institut Claudius Regaud** · enrollment: 30 (actual)

## Conditions studied

- Thyroid Cancer

## Interventions

- **OTHER:** Metabolites dosage

## Key facts

- **NCT ID:** NCT04821336
- **Lead sponsor:** Institut Claudius Regaud
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-15
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-12-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04821336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04821336, "Cholesterol Metabolites Analysis in Human Thyroid and Iodine Resistance". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04821336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*